151 related articles for article (PubMed ID: 31591386)
1. Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.
de Jel MM; Schott M; Lamm S; Neuhuber W; Kuphal S; Bosserhoff AK
Oncogenesis; 2019 Oct; 8(10):56. PubMed ID: 31591386
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
3. UVB radiation represses CYLD expression in melanocytes.
Kuphal S; Schneider N; Massoumi R; Hellerbrand C; Bosserhoff AK
Oncol Lett; 2017 Dec; 14(6):7262-7268. PubMed ID: 29344161
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Schott M; Kappelmann-Fenzl M; Fischer S; Fernandez-Barrena MG; Pineda-Lucena A; Ávila MA; Kuphal S; Bosserhoff AK
Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35293595
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
Oncotarget; 2018 Mar; 9(17):13407-13422. PubMed ID: 29568366
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
Orfanidou T; Xanthopoulos K; Dafou D; Pseftogas A; Hadweh P; Psyllaki C; Hatzivassiliou E; Mosialos G
Anticancer Res; 2017 Jul; 37(7):3493-3503. PubMed ID: 28668838
[TBL] [Abstract][Full Text] [Related]
7. Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma.
Deng M; Dai W; Yu VZ; Tao L; Lung ML
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708712
[TBL] [Abstract][Full Text] [Related]
8. miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma.
Qiu H; Yuan S; Lu X
Oncol Lett; 2016 Oct; 12(4):2301-2306. PubMed ID: 27698793
[TBL] [Abstract][Full Text] [Related]
9. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
Long J; Pi X
Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
[TBL] [Abstract][Full Text] [Related]
10. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
Zhang K; Guo L
Gene; 2018 Jan; 641():272-278. PubMed ID: 29054757
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of CYLD downregulation in breast cancer.
Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
[TBL] [Abstract][Full Text] [Related]
12. Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness.
Isola AL; Eddy K; Zembrzuski K; Goydos JS; Chen S
Oncotarget; 2018 Jan; 9(1):1187-1199. PubMed ID: 29416686
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
14. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goydos J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S
Nat Genet; 2003 May; 34(1):108-12. PubMed ID: 12704387
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
[TBL] [Abstract][Full Text] [Related]
16. Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63-linked polyubiquitin chains.
Jin C; Kim S; Kang H; Yun KN; Lee Y; Zhang Y; Kim Y; Kim JY; Han K
J Neurochem; 2019 Sep; 150(6):776-786. PubMed ID: 31215654
[TBL] [Abstract][Full Text] [Related]
17. Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes.
Marín YE; Namkoong J; Shin SS; Raines J; Degenhardt K; White E; Chen S
Neuropharmacology; 2005; 49 Suppl 1():70-9. PubMed ID: 16040064
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Namkoong J; Shin SS; Lee HJ; Marín YE; Wall BA; Goydos JS; Chen S
Cancer Res; 2007 Mar; 67(5):2298-305. PubMed ID: 17332361
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
Marín YE; Namkoong J; Cohen-Solal K; Shin SS; Martino JJ; Oka M; Chen S
Cell Signal; 2006 Aug; 18(8):1279-86. PubMed ID: 16305822
[TBL] [Abstract][Full Text] [Related]
20. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
